Translational research bridges the gap between laboratory discovery and clinical impact, transforming what we know into how we care.

The Translational Hematology program creates a dedicated home for clinician-scientists who live in both worlds by conducting research that emerges from patient encounters and applying discoveries that improve patient outcomes. These physician-investigators understand which questions matter most because they see patients who need answers.

Our translational research spans the full spectrum of blood disorders. We conduct epidemiological studies that reveal disease patterns and risk factors, evaluate diagnostic innovations and treatment protocols, and design clinical trials that test new therapeutic approaches.  

As co-leaders of the Recipient Epidemiology and Donor Evaluation Study (REDS-IV-P), we contribute to a national effort improving blood transfusion safety and effectiveness. Our researchers investigate transfusion practices, analyze outcomes, and identify opportunities to enhance care for patients who depend on blood products.